Nanoparticle Immunoadjuvant Complexes Augment Germinal Center Responses to Vaccination.

Area of Science:

• Immunology
• Vaccinology
• Nanotechnology

Background:

• Enhanced germinal center (GC) responses are crucial for effective humoral immunity against infectious diseases.
• Developing novel vaccine strategies to boost GC reactions and B cell maturation is a key goal in vaccinology.

Purpose of the Study:

• To investigate if scaffolding a cytokine onto a self-assembling nanoparticle immunogen can improve antigen-specific GC responses and B cell maturation.
• To evaluate the potential of nanoparticle immunoadjuvant complexes (NICs) as a vaccine platform.

Main Methods:

• Design of chimeric nanoparticles (GT8-IL-21-NICs) incorporating an HIV immunogen (eOD-GT8) and the cytokine IL-21.
• DNA delivery of GT8-IL-21-NICs in mice to assess immune responses.
• Transcriptomic analysis of GC B cells and evaluation of antibody diversity and mutations in mice with human bnAb precursor genes.

Main Results:

• GT8-IL-21-NIC immunization significantly enhanced serum antibody titers and antigen-specific GC B cell responses in mice.
• Transcriptomic analysis revealed upregulation of selection-associated gene signatures in GC B cells post-immunization.
• Immunization led to increased antibody diversity, clonal expansion, somatic hypermutation, and acquisition of key mutations in mice harboring human bnAb precursor genes.

Conclusions:

• IL-21 is a potent genetic adjuvant that can be effectively incorporated into NICs.
• NICs represent a promising platform for enhancing antigen-specific GC responses and improving vaccine-induced immunity.
• This approach holds potential for developing more effective vaccines against infectious diseases.